A synthetic analog of vasopressin with ORNITHINE substitution at residue 8 of the cyclic nonapeptide. It is used as a local vasoconstrictor and hemostatic.
Ornipressin has been studied across 13 research domains including 🫘 Kidney, ❤️ Cardiovascular, 🫁 Liver & Detox, 🧠 Focus & Attention, 🌤️ Mood & Depression. The primary research focus is 🫘 Kidney with 37% of studies addressing this area.
The following compounds share molecular targets with Ornipressin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Ornipressin is generated deterministically from 82 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.